Strong EPS and Margin Expansion
Adjusted EPS grew 22% year-over-year to $1.75 in Q2, supported by 70 basis points of year-over-year margin expansion. Adjusted EBITDA was $327 million, up more than 14%, with an adjusted EBITDA margin of 14.1%.
Robust Revenue and Backlog Growth
Gross revenue increased 27% year-over-year and adjusted net revenue (ex-pass-through) grew 9% (organic). Consolidated backlog grew 22% year-over-year to a record $27 billion, with a trailing 12-month book-to-bill of 1.4x on gross revenue (1.2x on net). Net revenue and gross profit in backlog increased 12% and 15% year-over-year, respectively.
Data Center and AI Acceleration
Data center revenue grew more than 100% year-over-year in Q2. The broader AI ecosystem (chips to power to data centers) represents ~10%–11% of revenue and is growing in excess of 40%. The AI infrastructure pipeline for data centers rose ~400% year-over-year with visibility into 2027–2028.
PA Consulting Acquisition and Performance
Completed the acquisition of PA Consulting. PA revenue grew 17% in Q2 with operating profit up 19% and an operating margin of 22%. Management expects PA to grow revenue high single digits (constant currency) in H2 and identified at least $20 million of annual cost synergies as integration scales.
Upgraded FY2026 Guidance
Raised FY2026 guidance: organic net revenue growth to 8.0%–10.5%, adjusted EBITDA margin to 14.6%–14.9%, and adjusted EPS to $7.10–$7.35 (implying ~18% year-over-year adjusted EPS growth at the midpoint). Q3 margin guide ~15% and Q4 >16% (extra week included).
Industry Recognition and Key Contracts
Named #1 design firm by Engineering News-Record (2026 Top 500). Secured notable awards including San Francisco Southeast Wastewater Treatment Plant, Ofwat consultancy engagement, DFW Terminal F lead designer, and multiple hyperscaler data center wins (including a digital twin built with NVIDIA).
End Market Diversification and Strong Segments
Life Sciences & Advanced Manufacturing net revenue grew 12% (highest since end-market reporting) and Critical Infrastructure net revenue grew 9%, led by transportation and energy & power. Life sciences pipeline up 81% year-over-year.
Active Capital Returns and Improved Financing
Share repurchases totaled $472 million in H1, ahead of the annual target of returning at least 60% of free cash flow. Net leverage ended the quarter at 2.1x (weighted average interest rate ~5%), with a plan to return below 2.0x by year-end and toward ~1.5x in FY2027.